Extracellular vesicles during the three trimesters of pregnancy

• Published in: Journal of reproductive immunology 2023-09, Vol.159, p.103987, Article 103987
• Main Authors: Buca, Danilo, Lucidi, Alessandro, Buca, Davide Vincenzo, Di Sebastiano, Francesca, D’Angelo, Emanuela, Vespa, Simone, Liberati, Marco, Lanuti, Paola, D’Antonio, Francesco
• Format: Article
• Language: English
• Subjects: Extracellular vesicles; Fresh peripheral blood; Platelet; Pregnancy
• ISSN: 0165-0378; 1872-7603; 1872-7603
• DOI: 10.1016/j.jri.2023.103987

Extracellular vesicles (EVs) are cell-derived particles released during different pathophysiological processes and emerging as relevant players in inter-cellular crosstalk. Previous studies have highlighted the role of EVs as potential biomarkers for several pregnancy complications, including miscarriage, pre-eclampsia and gestational diabetes. Despite that, the actual distribution of EVs through gestation has not been reported yet. The aim of this study was to report the concentration of different sub-types of EVs in the first, second and third trimester of pregnancy and to correlate them with different pregnancy and ultrasound characteristics. Prospective observational study including uncomplicated pregnancies in the first, second and third trimester of pregnancy. The first aim of the study was to report the concentration of the EVs derived from endothelial, epithelial, platelet and leukocyte cells of maternal peripheral blood samples in the first, second and third trimester pregnancy using polychromatic flow cytometry. The secondary aim was to correlate EVs with neonatal birthweight and fetal Dopplers, including uterine and umbilical arteries. Un and multivariate analyses were used to compute the data. 64 women (20 in the first, 22 in the second and 22 in the third trimester of pregnancies) were included in the analysis. There was no difference in the median concentration of either platelet, leukocyte and endothelial EVs between the first, second and third trimester of pregnancy. The concentration of epithelial derived EVs was higher in the third compared to first and second trimester of pregnancy. When analyzing the percentage of EV vesicles through gestation, there was no difference in the percentage of either leukocyte or endothelial EVs through gestation. Conversely, the median percentage of platelet derived vesicles was higher in the first (48.7 %, IQR 34.1–58.5) compared to second (34.0 %, IQR 22.7–44.9) and third (9.13 %, IQR 5.01–12.1) trimester of pregnancy, while the median percentage of third trimester (6.01, IQR 2.42–7.34) epithelial derived vesicles was higher than that of the second (1.53 %, IQR 0.65–2.98), but not of the first (4.45 %, IQR 1.44–6.07) trimester. Finally, we found no association between the median concentration or percentage of endothelial, epithelial, leukocyte vesicles, neonatal birthweight and fetal or maternal Dopplers. Distribution of EVs examined does not change during the three trimesters of pregnancy and is not infl